Moreover, ATP-citrate lyase, a cytosolic enzyme that catalyzes the generation of acetyl-CoA from citrate of mitochondrial origin, is upregulated in cancer and its inhibition suppresses the proliferation of various types of tumor cells (as reviewed in [32]), making this enzyme a therapeutic target for cancer. The gene discussed is ACLY; the disease is neoplasm.